
Serostim Therapy Reduces Hospitalization Rates in American Males with Severe Infections
Reading Time: 2 minutes Introduction In the realm of medical science, the quest for effective treatments to combat severe infections remains a priority, particularly among vulnerable populations such as American males. Serostim, a recombinant human growth hormone, has been traditionally used to treat AIDS-related wasting and cachexia. However, recent studies suggest its potential in reducing hospitalization rates among patients with severe infections. This article delves into a retrospective analysis of data from major hospitals across the United States, focusing on the efficacy of Serostim therapy in this context. Background on Serostim Therapy Serostim, generically known as somatropin, is a biosynthetic growth hormone that has...